Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0468.HK Stock Summary
Top 10 Correlated ETFs
0468.HK
In the News
0468.HK Financial details
Company Rating
Buy
Market Cap
2.74B
Income
422.75M
Revenue
7.74B
Book val./share
2.06
Cash/share
0.37
Dividend
-
Dividend %
-
Employees
1.79K
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
11.82
Forward P/E
9.55
PEG
2.23
P/S
0.55
P/B
0.82
P/C
5.68
P/FCF
8.4
Quick Ratio
0.38
Current Ratio
1.82
Debt / Equity
0.05
LT Debt / Equity
0
-
-
EPS (TTM)
0.32
EPS next Y
0.22
EPS next Q
-
EPS this Y
-33.33%
EPS next Y
-31.4%
EPS next 5Y
-31.4%
EPS last 5Y
-12.31%
Revenue last 5Y
9.57%
Revenue Q/Q
-12.64%
EPS Q/Q
-13.24%
-
-
-
-
SMA20
9.78%
SMA50
10.99%
SMA100
-
Inst Own
0.02%
Inst Trans
0.5%
ROA
4%
ROE
7%
ROC
0.08%
Gross Margin
15%
Oper. Margin
6%
Profit Margin
5%
Payout
-
Shs Outstand
0
Shs Float
0
-
-
-
-
Target Price
-
52W Range
1.47-2.43
52W High
+5%
52W Low
+110%
RSI
65.27
Rel Volume
45.22
Avg Volume
1.51M
Volume
68.24M
Perf Week
6.06%
Perf Month
22.09%
Perf Quarter
1.45%
Perf Half Y
-5.41%
-
-
-
-
Beta
1.263
-
-
Volatility
0.03%, 0.1%
Prev Close
2.44%
Price
2.1
Change
5.53%
0468.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.86 | 2.02 | 2.27 | 2.59 | 2.95 | |
Net income per share | 0.27 | 0.25 | 0.26 | 0.21 | 0.14 | |
Operating cash flow per share | 0.29 | 0.26 | 0.39 | 0.1 | 0.26 | |
Free cash flow per share | 0.21 | 0.24 | 0.33 | 0.03 | 0.19 | |
Cash per share | 0.42 | 0.42 | 0.43 | 0.32 | 0.45 | |
Book value per share | 1.82 | 1.83 | 1.86 | 1.81 | 1.96 | |
Tangible book value per share | 1.76 | 1.75 | 1.79 | 1.75 | 1.91 | |
Share holders equity per share | 1.82 | 1.83 | 1.86 | 1.81 | 1.96 | |
Interest debt per share | 0.14 | 0.25 | 0.16 | 0.23 | 0.18 | |
Market cap | 4.99B | 4.26B | 5.06B | 3.11B | 1.72B | |
Enterprise value | 4.62B | 4.03B | 4.7B | 3B | 1.36B | |
P/E ratio | 13.85 | 12.63 | 14.77 | 10.91 | 9.45 | |
Price to sales ratio | 2 | 1.57 | 1.67 | 0.9 | 0.44 | |
POCF ratio | 12.77 | 12.03 | 9.73 | 23.23 | 4.99 | |
PFCF ratio | 17.81 | 13.05 | 11.49 | 67.78 | 6.69 | |
P/B Ratio | 2.04 | 1.74 | 2.03 | 1.28 | 0.66 | |
PTB ratio | 2.04 | 1.74 | 2.03 | 1.28 | 0.66 | |
EV to sales | 1.85 | 1.49 | 1.55 | 0.86 | 0.34 | |
Enterprise value over EBITDA | 8.62 | 7.38 | 7.84 | 6.21 | 3.77 | |
EV to operating cash flow | 11.83 | 11.38 | 9.03 | 22.38 | 3.93 | |
EV to free cash flow | 16.5 | 12.35 | 10.67 | 65.29 | 5.27 | |
Earnings yield | 0.07 | 0.08 | 0.07 | 0.09 | 0.11 | |
Free cash flow yield | 0.06 | 0.08 | 0.09 | 0.01 | 0.15 | |
Debt to equity | 0.08 | 0.13 | 0.08 | 0.12 | 0.09 | |
Debt to assets | 0.06 | 0.09 | 0.06 | 0.08 | 0.06 | |
Net debt to EBITDA | -0.68 | -0.42 | -0.61 | -0.24 | -1.02 | |
Current ratio | 2.71 | 1.98 | 2.06 | 1.94 | 1.82 | |
Interest coverage | 168.79 | 79 | 100.26 | 107.53 | 42.14 | |
Income quality | 1.08 | 1.05 | 1.52 | 0.47 | 1.89 | |
Dividend Yield | 0.06 | 0.08 | 0.06 | 0.09 | 0 | |
Payout ratio | 0.84 | 0.95 | 0.94 | 1.01 | 0 | |
Sales general and administrative to revenue | 0.05 | 0.05 | 0.06 | 0.05 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 | |
Capex to operating cash flow | -0.28 | -0.08 | -0.15 | -0.66 | -0.25 | |
Capex to revenue | -0.04 | -0.01 | -0.03 | -0.03 | -0.02 | |
Capex to depreciation | -0.96 | -0.19 | -0.52 | -0.62 | -0.63 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.32 | 3.23 | 3.28 | 2.95 | 2.45 | |
ROIC | 0.13 | 0.11 | 0.13 | 0.1 | 0.06 | |
Return on tangible assets | 0.11 | 0.1 | 0.1 | 0.08 | 0.04 | |
Graham Net | 0.28 | 0.13 | 0.17 | 0.1 | 0.07 | |
Working capital | 1.13B | 995.66M | 1.08B | 1.07B | 1.3B | |
Tangible asset value | 2.35B | 2.34B | 2.4B | 2.33B | 2.56B | |
Net current asset value | 1.01B | 871.43M | 967.44M | 972.66M | 1.23B | |
Invested capital | 0.08 | 0.13 | 0.08 | 0.12 | 0.09 | |
Average receivables | 378.28M | 495.34M | 575.19M | 647.89M | 731.32M | |
Average payables | 373.34M | 432.26M | 523.12M | 596.86M | 806.04M | |
Average inventory | 587.9M | 599.43M | 668.94M | 754.67M | 990.24M | |
Days sales outstanding | 60.53 | 77.85 | 68.83 | 76.15 | 68.6 | |
Days payables outstanding | 71.13 | 89.37 | 89.41 | 85.31 | 105.22 | |
Days of inventory on hand | 111.31 | 112.28 | 116.16 | 105.36 | 128.81 | |
Receivables turnover | 6.03 | 4.69 | 5.3 | 4.79 | 5.32 | |
Payables turnover | 5.13 | 4.08 | 4.08 | 4.28 | 3.47 | |
Inventory turnover | 3.28 | 3.25 | 3.14 | 3.46 | 2.83 | |
ROE | 0.15 | 0.14 | 0.14 | 0.12 | 0.07 | |
Capex per share | -0.08 | -0.02 | -0.06 | -0.07 | -0.07 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.16 | 1.43 | 1.33 | 1.62 | 1.41 | |
Net income per share | 0.11 | 0.11 | 0.05 | 0.09 | 0.07 | |
Operating cash flow per share | -0.01 | 0.11 | 0.13 | 0.13 | 0 | |
Free cash flow per share | -0.05 | 0.08 | 0.11 | 0.08 | -0.01 | |
Cash per share | 0.34 | 0.32 | 0.44 | 0.45 | 0.37 | |
Book value per share | 1.84 | 1.81 | 1.85 | 1.96 | 2.06 | |
Tangible book value per share | 1.77 | 1.75 | 1.78 | 1.91 | 2.02 | |
Share holders equity per share | 1.84 | 1.81 | 1.85 | 1.96 | 2.06 | |
Interest debt per share | 0.11 | 0.22 | 0.23 | 0.18 | 0.11 | |
Market cap | 3.9B | 3.11B | 1.79B | 1.72B | 2.66B | |
Enterprise value | 3.6B | 3B | 1.53B | 1.36B | 2.3B | |
P/E ratio | 6.74 | 5.53 | 6.65 | 3.75 | 6.65 | |
Price to sales ratio | 2.51 | 1.62 | 1.01 | 0.8 | 1.41 | |
POCF ratio | -346.32 | 21.43 | 10.72 | 9.68 | -799.42 | |
PFCF ratio | -58.06 | 27.52 | 12.2 | 15.57 | -144.29 | |
P/B Ratio | 1.59 | 1.28 | 0.73 | 0.66 | 0.96 | |
PTB ratio | 1.59 | 1.28 | 0.73 | 0.66 | 0.96 | |
EV to sales | 2.32 | 1.56 | 0.86 | 0.63 | 1.22 | |
Enterprise value over EBITDA | 13.84 | 13.49 | 9.92 | 6.61 | 12.54 | |
EV to operating cash flow | -319.98 | 20.64 | 9.15 | 7.62 | -693.44 | |
EV to free cash flow | -53.64 | 26.51 | 10.41 | 12.25 | -125.16 | |
Earnings yield | 0.04 | 0.05 | 0.04 | 0.07 | 0.04 | |
Free cash flow yield | -0.02 | 0.04 | 0.08 | 0.06 | -0.01 | |
Debt to equity | 0.06 | 0.12 | 0.13 | 0.09 | 0.05 | |
Debt to assets | 0.04 | 0.08 | 0.08 | 0.06 | 0.04 | |
Net debt to EBITDA | -1.14 | -0.51 | -1.71 | -1.79 | -1.92 | |
Current ratio | 1.99 | 1.94 | 1.93 | 1.82 | 2.36 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | -0.08 | 1.03 | 2.48 | 1.55 | -0.03 | |
Dividend Yield | 0 | 0.09 | 0 | 0 | 0 | |
Payout ratio | 0 | 2.05 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Intangibles to total assets | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | |
Capex to operating cash flow | 4.96 | -0.22 | -0.12 | -0.38 | 4.54 | |
Capex to revenue | -0.04 | -0.02 | -0.01 | -0.03 | -0.01 | |
Capex to depreciation | -0.73 | -0.49 | -0.28 | -1.03 | -0.21 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.11 | 2.07 | 1.45 | 1.95 | 1.86 | |
ROIC | 0.05 | 0.05 | 0.02 | 0.04 | 0.03 | |
Return on tangible assets | 0.04 | 0.04 | 0.02 | 0.03 | 0.03 | |
Graham Net | 0.11 | 0.1 | 0.13 | 0.07 | 0.31 | |
Working capital | 1.07B | 1.07B | 1.18B | 1.3B | 1.44B | |
Tangible asset value | 2.36B | 2.33B | 2.39B | 2.56B | 2.7B | |
Net current asset value | 972.08M | 972.66M | 1.09B | 1.23B | 1.36B | |
Invested capital | 0.06 | 0.12 | 0.13 | 0.09 | 0.05 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 33.82 | 33.97 | 33.55 | 30.79 | 33.52 | |
Days payables outstanding | 41.15 | 37.04 | 43.36 | 47.36 | 34.82 | |
Days of inventory on hand | 65.38 | 45.74 | 54.19 | 57.97 | 59.8 | |
Receivables turnover | 2.66 | 2.65 | 2.68 | 2.92 | 2.68 | |
Payables turnover | 2.19 | 2.43 | 2.08 | 1.9 | 2.59 | |
Inventory turnover | 1.38 | 1.97 | 1.66 | 1.55 | 1.51 | |
ROE | 0.06 | 0.06 | 0.03 | 0.04 | 0.04 | |
Capex per share | -0.04 | -0.02 | -0.02 | -0.05 | -0.01 |
0468.HK Frequently Asked Questions
What is Greatview Aseptic Packaging Company Limited stock symbol ?
Greatview Aseptic Packaging Company Limited is a CN stock and trading under the symbol 0468.HK
What is Greatview Aseptic Packaging Company Limited stock quote today ?
Greatview Aseptic Packaging Company Limited stock price is $2.1 today.
Is Greatview Aseptic Packaging Company Limited stock public?
Yes, Greatview Aseptic Packaging Company Limited is a publicly traded company.